NATICK, Mass.–(BUSINESS WIRE)–Allurion Technologies, a pioneering chief within the improvement of revolutionary, scalable and trusted weight reduction experiences, in the present day introduced new medical knowledge on the Elipse Balloon at ObesityWeek 2020. The Allurion Program options the Elipse Balloon, the world’s first and solely procedureless weight reduction gadget. The balloon is designed to stay within the abdomen for 4 months and is paired with a Bluetooth® linked scale and Allurion smartphone app and a supervised dietary program.
In Lengthy-Time period Efficacy of the Elipse Gastric Balloon System: An Worldwide Multicenter Examine, Dr. Roberta Ienca and colleagues report on 509 sufferers who acquired the Elipse Balloon and have been adopted for one 12 months. After 4 months of Elipse Balloon remedy sufferers achieved weight lack of 14.4 ± 7.7kg or 13.9 ± 6.4% of complete physique weight. At one-year follow-up, 95% of this weight reduction was sustained.
In Sequential Elipse Balloon Therapy: 1-Yr Weight Loss Outcomes Approximates Bariatric Surgical procedure Outcomes, Dr. Roberta Ienca and colleagues report on 42 sufferers handled with sequential Elipse Balloons. Between one and 5 months following the passing of the primary Elipse Balloon, a second balloon was positioned. After 4 months, imply weight reduction and % complete physique weight reduction have been 14.7 ± 4.4kg and 14.4 ± 3.6%, respectively. The second balloon resulted in an extra 8.8 ± 5.7kg and 10.0 ± 6.5% weight reduction, respectively. In complete, sequential balloon remedy resulted in weight lack of 22.0 +/- 9.0kg or 22.8 +/- 8.8%, and a physique mass index (BMI) lower of 8.1kg/m2 from baseline.
“Each of those research exhibit the potential that the Allurion Program has in offering customers with long-term and sustainable outcomes,” mentioned Dr. Shantanu Gaur, co-founder and CEO of Allurion. “Moreover, this knowledge signifies that buyers can obtain life-changing outcomes without having to bear surgical procedure, endoscopy or anesthesia.”
“The Elipse Balloon offers my sufferers with a major weight reduction instrument and an alternative choice to weight reduction surgical procedure,” mentioned Dr. Alberto Pagan, Clinica CINIB, Palma de Mallorca, Spain. “These outcomes underscore how the Allurion Program can ship each brief and long-term outcomes that meet the expectations of my sufferers.”
“The medical knowledge introduced at Weight problems Week is reflective of the growing demand for our product all over the world,” mentioned Benoit Chardon, Government Vice President Business for Allurion. “We now have tripled the variety of sufferers handled prior to now 12 months and have created a status for medical outcomes that suppliers and sufferers can belief.”
About Allurion Applied sciences
Allurion Technologies is devoted to serving to folks understand their full potential with revolutionary, scalable and trusted experiences. The corporate’s flagship product, the Allurion Program, is a 360-degree weight reduction expertise that includes the Elipse Balloon, the world’s first and solely swallowable, procedureless gastric balloon for weight reduction. Study extra in regards to the Elipse Balloon and Allurion on-line at www.allurion.com, on Fb at www.fb.com/allurion or on Twitter @alluriontech.
